WST - Multiplikator P/S West Pharmaceutical Services Inc
Demand for FluroTec components for obesity drugs is driving growth, and consequently, the P/S history on GURU.Markets shows the current value is 8.60. West Pharmaceutical Services (WST) relies on stringent FDA requirements for sterile packaging, creating significant barriers to entry for competitors. The company's monopolization of the injectable vial and stopper market secures its unique position within the biopharmaceutical sector.
West Pharmaceutical Services Inc (WST) - rincian metrik lan laporan keuangan
- rega saham lan konsensus proyeksi valuasi:
- statistik kapitalisasi pasar:
- data ekuitas miturut neraca:
- indikator beban kredit lan likuiditas emiten:
Rasio Utang marang Ekuitas West Pharmaceutical Services|WST - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal westpharma.com|WST - Utang perusahaan|Utang-utang marang aset resik West Pharmaceutical Services, Inc.|WST - Kewajiban jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan West Pharmaceutical Services|Likuiditas darurat westpharma.com
- data bathi bisnis lan rasio investasi:
WST - Bathi resik perusahaan|Prakiraan bathi perusahaan West Pharmaceutical Services|WST - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep West Pharmaceutical Services|WST - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan West Pharmaceutical Services|WST - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben siji saham sajrone 12 wulan pungkasan West Pharmaceutical Services|WST - Bathi resik saben saham (EPS TTM)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan westpharma.com|WST - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep West Pharmaceutical Services
- rincian pendapatan lan dodolan emiten:
Analisis fundamental perusahaan:WST, West Pharmaceutical Services Inc
The selection of high-quality issuers is based on comparing market capitalization with actual sales volume to determine the fair value of the business. The P/S ratio measures the price per unit of revenue, which in the case of West Pharmaceutical Services (WST) allows for an assessment of the monetization efficiency of robotic component sterilization lines through an analysis of this chart's price action.
Karo sapa West Pharmaceutical Services saingan
Kapitalisasi marang volume dodolan ISRG|Danaher Corporation - Kapitalisasi marang pendapatan|Multiplikator P/S Becton Dickinson & Company BDX|STE - Rasio rega marang pendapatan|Baxter International (BAX) - Kapitalisasi marang pendapatan|Masimo Corp (MASI) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan Stevanato Group|Rasio rega marang pendapatan Teleflex Incorporated|Rega marang dodolan Merit Medical Corp MMSI|Rasio rega marang pendapatan Envista (NVST)|ICU Medical - Rasio kapitalisasi marang pendapatan|DENTSPLY SIRONA Inc. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan LMAT (LeMaitre Vascular Inc)|ATRC - Rasio rega marang pendapatan|Koefisien rega marang pendapatan STAAR Surgical Co STAA|NAGE: Multiplikator P/S|Rasio rega marang dodolan ZIMV (ZimVie Inc.)|Rasio rega marang pendapatan AngioDynamics Corp|Rega marang dodolan Cerus Corp. CERS|Rasio rega marang pendapatan Teknova (TKNO)|Monogram Orthopedics Inc. - Rasio kapitalisasi marang pendapatan|Rasio rega marang pendapatan Sharps Technology, Inc. STSS|Multiplikator P/S InfuSystem Holdings INFU|UTMD: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan KRMD (KORU Medical)|NYXH: Multiplikator P/S|MBOT (Microbot Medical, Inc) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan PDEX|ZTEK: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S ELUT|Milestone Scientific Inc. - Rasio kapitalisasi marang pendapatan|Rasio rega marang pendapatan NEXGEL, Inc. NXGL|Retractable Tech - Rasio rega marang pendapatan|harvardbioscience.com - Multiplikator P/S|FEMY (Femasys Inc.) - Rasio kapitalisasi marang pendapatan|MHUA: Multiplikator P/S|Predictive Oncology Corp - Rasio kapitalisasi pasar marang pendapatan|CJMB (Callan JMB) - Multiplikator P/S|Rega marang dodolan Atrion Corporation Inc. ATRI|Multiplikator P/S NURO
